According to a study by researchers at the Ragon Institute of Massachusetts General Hospital (MGH), MIT, and Harvard, an additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2.
Read More
